Growth Metrics

Wave Life Sciences (WVE) EBT Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (1y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 12.59%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -148.28%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -313.33%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 71.54%
7 Evaxion A 64.16 Bn 64.14 Bn - -79.57%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -8.15%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 9,460.35%
10 Wave Life Sciences 1.32 Bn 772.50 Mn - 44.35%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 44.35%
Dec 31, 2025 -281.79%
Sep 30, 2025 12.83%
Jun 30, 2025 -53.29%
Mar 31, 2025 -48.55%
Dec 31, 2024 279.95%
Sep 30, 2024 -1,039.62%
Jun 30, 2024 -56.00%
Mar 31, 2024 -15.15%
Dec 31, 2023 62.22%
Sep 30, 2023 116.86%
Jun 30, 2023 48.90%
Mar 31, 2023 27.53%
Dec 31, 2022 -22.98%
Sep 30, 2022 -526.07%
Jun 30, 2022 -6.53%
Mar 31, 2022 10.95%
Dec 31, 2021 -18.09%
Sep 30, 2021 81.18%
Jun 30, 2021 4.35%
Mar 31, 2021 10.59%
Dec 31, 2020 47.81%
Sep 30, 2020 34.75%
Jun 30, 2020 3.37%
Mar 31, 2020 -7.45%
Dec 31, 2019 -49.43%
Sep 30, 2019 -34.80%
Jun 30, 2019 -16.85%
Mar 31, 2019 -26.04%
Dec 31, 2018 -22.60%
Sep 30, 2018 -45.23%
Jun 30, 2018 -47.99%
Mar 31, 2018 -75.47%
Dec 31, 2017 -66.07%
Sep 30, 2017 -51.08%
Jun 30, 2017 -110.59%
Mar 31, 2017 -154.53%
Dec 31, 2016 -157.81%
Sep 30, 2016 -253.41%
Jun 30, 2016 -215.45%
Mar 31, 2016 -129.93%
Dec 31, 2015 -311.43%
Sep 30, 2015 -265.16%